News - BIOQuébec

22 October 2026
MFI releases Canopy, a chemistry-first decision intelligence platform for small-molecule discovery
Molecular Forecaster Inc. (MFI) today announces the launch of Canopy, a new…
Read more
22 October 2026
Médicament Québec Invests $1.2 Million in Four Industry–Academia Collaborations to Accelerate Drug Development
Médicament Québec is proud to announce a $1.2 million investment, made possible through the support…
Read more
6 October 2026
BIOQuébec congratulates the Parti Québécois and offers its cooperation to increase prosperity and improve the health of Quebecers
BIOQuébec congratulates the Parti Québécois and Paul St-Pierre Plamondon, premier-designate…
Read more
2 October 2026
French company AdBio Partners sets up operations in Montreal
The French firm AdBio Partners, which manages nearly 275 million euros in funds…
Read more
2 October 2026
Health Canada Approves DAWNZERA® (donidalorsen) for the Prevention of Hereditary Angioedema Attacks
Approval marks CELYSTRA Pharma’s second product approved by Health Canada in…
Read more
2 October 2026
Biodextris Appoints Clement Fourny as Chief Executive Officer
Seasoned life sciences leader joins Laval-based CDMO to drive next…
Read more

MFI releases Canopy, a chemistry-first decision intelligence platform for small-molecule discovery

Molecular Forecaster Inc. (MFI) today announces the launch of Canopy, a new…